Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.42 |
| ▸ | GPR174 | Q9BXC1 | 4/20 | 0.42 |
| ▸ | LAP3 | P28838 | 4/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL540875 | 1.00 | SLC7A5 (0.46) | SLC7A5P2RY10GPR174LAP3SLC1A3 | |
| SCHEMBL13308410 | 1.00 | SLC7A5 (0.46) | SLC7A5P2RY10GPR174LAP3SLC1A3 | |
| SCHEMBL27534147 | 0.98 | SLC7A5 (0.44) | SLC7A5P2RY10GPR174LAP3SLC1A3 | |
| Glycine SCHEMBL10277138 | 0.91 | P2RY10 (0.40) | SLC7A5P2RY10GPR174LAP3SLC1A3 | |
| SCHEMBL29687290 | 0.88 | LAP3 (0.35) | SLC7A5P2RY10GPR174LAP3 | |
| SCHEMBL12609432 | 0.85 | SLC7A5 (0.44) | SLC7A5P2RY10GPR174LAP3SLC1A3 | |
| Dexfosfoserine SCHEMBL6513515 | 0.85 | PGK1 (0.43) | P2RY10GPR174 | |
| SCHEMBL8934990 | 0.84 | GPR174 (0.44) | SLC7A5P2RY10GPR174LAP3SLC1A3 | |
| Glutamine SCHEMBL6864537 | 0.82 | ALOX15 (0.56) | P2RY10GPR174SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2232197 | 0.81 | SLC7A5 (0.44) | SLC7A5P2RY10GPR174LAP3SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 18563 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070942-A | Implant adhesive and preparation method and application thereof | 杭州源囊生物科技有限公司 | 2026-05-22 | — | — | CN | claimed |
| WO-2026102249-A1 | TNF RECEPTOR SUPERFAMILY AGONIST FUSION POLYPEPTIDES | ANKYRA THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| CN-122028898-A | Novel short-chain peptides and derivatives thereof | 艾缇亚(上海)制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4731305-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2026-04-29 | — | — | EP | claimed |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| EP-4709434-A1 | CALCIUM PHOSPHATE POWDER COMPOSITION | Biomimetic Innovations Limited (IE) | 2026-03-18 | — | — | EP | claimed |
| US-20260062469-A1 | COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME | ABBRATECH INC (US) | 2026-03-05 | — | — | US | claimed |
| US-20260021177-A1 | IMMUNOMODULATORY FUSION PROTEIN-METAL HYDROXIDE COMPLEXES AND METHODS THEREOF | MASSACHUSETTS INST TECHNOLOGY (US) | 2026-01-22 | — | — | US | claimed |
| US-12509508-B2 | Compositions and methods for linear and conformational site-specific antibodies and methods of making the same | ABBRATECH, INC. (US) | 2025-12-30 | — | — | US | claimed |
| EP-4665372-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| US-4868287-A | ANTIDEPOSIT | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-09-19 | — | — | US | claimed |
| US-4866161-A | Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof which have a clustered block copolymer structure | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-09-12 | — | — | US | claimed |
| EP-0305282-A1 | Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-03-01 | — | — | EP | claimed |
| EP-0305283-A2 | Inhibition of mineral deposition by polyanionic/hydrophobic peptides and derivatives thereof | UNIVERSITY OF SOUTH ALABAMA (US) | 1989-03-01 | — | — | EP | claimed |
| EP-0268663-A1 | PHOSPHOPEPTIDES. | UNIV MELBOURNE (AU) | 1988-06-01 | — | — | EP | claimed |
| WO-1987007615-A1 | PHOSPHOPEPTIDES | THE UNIVERSITY OF MELBOURNE (AU) | 1987-12-17 | — | — | WO | claimed |
| EP-0166055-A2 | Caries inhibition | THE UNIVERSITY OF MELBOURNE (AU) | 1986-01-02 | — | — | EP | claimed |
| EP-0073210-A4 | CARIES INHIBITION. | UNIV MELBOURNE (AU) | 1985-06-10 | — | — | EP | claimed |
| EP-0073210-A1 | CARIES INHIBITION. | UNIV MELBOURNE (AU) | 1983-03-09 | — | — | EP | claimed |
| WO-1982003008-A1 | CARIES INHIBITION | REYNOLDS ERIC CHARLES | 1982-09-16 | — | — | WO | claimed |